Constellium N.V. (NYSE:CSTM) has earned an average recommendation of “Buy” from the six analysts that are currently covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average twelve-month price target among brokers that have covered the stock in the last year is $8.77.

A number of brokerages have recently issued reports on CSTM. BidaskClub raised Constellium N.V. from a “hold” rating to a “buy” rating in a research note on Tuesday, August 1st. Seaport Global Securities cut Constellium N.V. from a “buy” rating to a “neutral” rating and raised their price objective for the company from $8.00 to $9.00 in a research note on Friday, July 28th. Cowen and Company set a $6.00 price objective on Constellium N.V. and gave the company a “hold” rating in a research note on Thursday, July 27th. Finally, BMO Capital Markets set a $9.00 price objective on Constellium N.V. and gave the company a “hold” rating in a research note on Friday, July 28th.

Several hedge funds have recently bought and sold shares of the company. Canyon Capital Advisors LLC acquired a new stake in Constellium N.V. during the first quarter valued at about $19,706,000. Evermore Global Advisors LLC acquired a new stake in Constellium N.V. during the second quarter valued at about $15,220,000. York Capital Management Global Advisors LLC acquired a new stake in Constellium N.V. during the first quarter valued at about $7,800,000. Rubric Capital Management LP acquired a new stake in Constellium N.V. during the first quarter valued at about $6,825,000. Finally, Boussard & Gavaudan Investment Management LLP boosted its stake in Constellium N.V. by 666.0% in the first quarter. Boussard & Gavaudan Investment Management LLP now owns 947,355 shares of the industrial products company’s stock valued at $6,347,000 after buying an additional 823,685 shares during the last quarter. 62.19% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION WARNING: This report was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another publication, it was illegally copied and reposted in violation of United States and international copyright laws. The original version of this report can be viewed at https://www.thecerbatgem.com/2017/08/27/constellium-n-v-cstm-receives-consensus-rating-of-buy-from-brokerages.html.

Shares of Constellium N.V. (NYSE:CSTM) remained flat at $10.30 during trading on Tuesday. 543,777 shares of the company’s stock traded hands. Constellium N.V. has a 52-week low of $4.85 and a 52-week high of $10.95. The company has a market cap of $1.09 billion, a PE ratio of 39.46 and a beta of 0.77. The firm has a 50 day moving average of $9.02 and a 200 day moving average of $7.36.

Constellium N.V. (NYSE:CSTM) last released its earnings results on Thursday, July 27th. The industrial products company reported $0.16 EPS for the quarter, missing the Zacks’ consensus estimate of $0.24 by $0.08. The firm had revenue of $1.38 billion during the quarter, compared to the consensus estimate of $1.43 billion. Constellium N.V. had a net margin of 0.48% and a negative return on equity of 4.31%. The firm’s revenue was up 12.1% compared to the same quarter last year. During the same period in the prior year, the company earned $0.08 EPS. Equities analysts anticipate that Constellium N.V. will post $0.61 EPS for the current year.

About Constellium N.V.

Constellium N.V. is a Netherlands-based company engaged in developing aluminum products for a range of markets and applications, including aerospace, automotive and packaging. The Company’s manufacturing facilities are located in the United States, Europe and China. It operates through three segments: Packaging & Automotive Rolled Product; Aerospace & Transportation, and Automotive Structures & Industry.

Analyst Recommendations for Constellium N.V. (NYSE:CSTM)

Receive News & Stock Ratings for Constellium N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Constellium N.V. and related stocks with our FREE daily email newsletter.